Overview

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Status:
Terminated

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy, safety and PK/PD of ocrelizumab at each dose in combination with methotrexate（MTX）in patients with active rheumatoid arthritis (RA). The data from this study will also be compared with those from a clinical study of ocrelizumab in patients with active RA that was conducted in the U.S.

Phase:

Phase 2

Details

Lead Sponsor:

Chugai Pharmaceutical

Treatments:

Methotrexate
Ocrelizumab